WASHINGTON - As researchers around the world search to find existing drugs that can be repurposed to treat COVID-19, the potential effectiveness of one drug was highlighted in a Senate hearing on early treatment for the virus.Ivermectin is an approved anti-parasitic drug known to be effective against a variety of viruses like influenza, dengue, and Zika.Dr.
Pierre Kory, a pulmonary and critical care specialist, passionately testified Tuesday before the Senate Committee on Homeland Security and Governmental Affairs during a hearing on "Early Outpatient Treatment: An Essential Part of a COVID-19 Solution."In his testimony, Kory said data shows the ability of ivermectin to prevent COVID-19, as well as its ability to keep those with early.